The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management.
about
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.Outcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasia.Prostatic hyperplasia is highly associated with nocturia and excessive sleepiness: a cross-sectional study.Medical and minimally invasive therapies for the treatment of benign prostatic hyperplasia.Understanding patient and physician perceptions of benign prostatic hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) SurveyPatient's and physician's behavior on the management of benign prostatic hyperplasia among the patients at the risk of clinical progression. A multicenter noninterventional trial in Slovakia by "Prostate and Expectations of Treatment: Epidemiology REmerging drugs for the treatment of benign prostatic hyperplasia.Real-world use of Permixon® in benign prostatic hyperplasia--determining appropriate monotherapy and combination treatment.OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes.[Prostate artery embolization (PAE) : Technique and results].Low serum testosterone levels are poor predictors of sexual dysfunction.Effect of dutasteride on the symptoms of benign prostatic hyperplasia, and patient quality of life and discomfort, in clinical practice.Patient centred care for the medical treatment of lower urinary tract symptoms in patients with benign prostatic obstruction: a key point to improve patients' care - a systematic review.The role of uroflowmetry in the assessment and management of men with lower urinary tract symptoms – revisiting the evidence
P2860
Q34639437-EF840F5A-9092-4B9C-B7AF-9E46E51E8A7CQ35989759-498A0517-D2B1-4E74-B542-723D94A29F91Q36008005-34559300-A9DA-4FDB-BB2D-4CE955BD54F5Q36498032-95DA5ED5-0B5A-47C0-A68B-471770539A4AQ36499690-6D12E3B7-F5DD-44B7-8C19-C7F153A24F3FQ40267326-F6A6BF10-EEBA-4482-9D77-E7FB4D1631DCQ47553287-AD81315A-6173-4D7B-B7D4-7AA2AF8C5E50Q47694772-8CF7E2C8-ABB9-4FF6-8F96-F2E2BEAF1385Q47978895-380CD38B-DFC0-4660-BBDD-5B6E9B81EFF8Q52665620-FAE772B1-42A4-484B-8715-9C64AE86A6ACQ53165880-1AE6AD84-2104-406A-AEE0-3166FF82F891Q53236407-31D64E87-2B48-4625-903A-17EBC04E7923Q55437967-037AFE96-5ED5-44EE-9862-54B0A8BB1686Q58461216-6F86DFC7-89B0-49CF-84C0-FC9F7562CE84
P2860
The importance of patient perception in the clinical assessment of benign prostatic hyperplasia and its management.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The importance of patient perc ...... yperplasia and its management.
@ast
The importance of patient perc ...... yperplasia and its management.
@en
type
label
The importance of patient perc ...... yperplasia and its management.
@ast
The importance of patient perc ...... yperplasia and its management.
@en
prefLabel
The importance of patient perc ...... yperplasia and its management.
@ast
The importance of patient perc ...... yperplasia and its management.
@en
P2093
P2860
P1433
P1476
The importance of patient perc ...... yperplasia and its management.
@en
P2093
Luc Valiquette
Sung Joon Hong
Walter Rayford
P2860
P356
10.1111/J.1464-410X.2005.05240.X
P577
2005-01-01T00:00:00Z